Fig. 2
From: Perfusion CT and PET with 18F–FDG and 18F–FCh in the complex diagnosis of hepatocellular carcinoma
PET/CT with 18F–FDG and 18F–FCh in low-differentiated hepatocellular carcinoma. Patient (a). Low-differentiated hepatocellular carcinoma. Images of axial projections of PET (a, c) and combined images of PET/CT (b, d) with 18F–FDG (a, b) and with 18F–FCh (c, d). With PET/CT with 18F–FDG in the right lobe of the liver, the focus of pathological accumulation of the radiopharmaceutical agent (red arrows) is visualized. With PET/CT with 18F–FCh, the pathological accumulation of 18F–FCh in the liver is not determined